Skip to main content

Stefanie Sarantopoulos

Chief of Hematologic Malignancies and Cellular Therapy
Medicine, Hematologic Malignancies and Cellular Therapy
Duke Blood Cancer Center 2400 Pratt St., Suite 5000, Box 3961, Durham, NC 27705
2400 Pratt Street Floor 5, Box 3961, Durham, NC 27710

Current Appointments & Affiliations


Chief of Hematologic Malignancies and Cellular Therapy · 2024 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine
Professor of Medicine · 2020 - Present Medicine, Hematologic Malignancies and Cellular Therapy, Medicine
Professor of Integrative Immunobiology · 2020 - Present Integrative Immunobiology, Basic Science Departments
Member of the Duke Cancer Institute · 2013 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


A More MAGICal Alogrithm in Acute GVHD.

Journal Article Transplant Cell Ther · April 2024 Full text Link to item Cite

Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.

Journal Article JCO Oncol Pract · March 2024 PURPOSE: We investigated the prevalence of financial toxicity in a population undergoing hematopoietic cell transplantation (HCT) evaluation and measured its impact on post-transplant clinical and health-related quality-of-life outcomes. MATERIALS AND METH ... Full text Link to item Cite

Patient-reported treatment response in chronic graft-versus-host disease.

Journal Article Haematologica · January 1, 2024 Chronic graft-versus-host disease (GvHD) treatment response is assessed using National Institutes of Health (NIH) Consensus Criteria in clinical trials, and by clinician assessment in routine practice. Patient-reported treatment response is central to the ... Full text Link to item Cite
View All Publications

Recent Grants


Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

The Duke Preparing Research scholars In bioMEdical sciences (PRIME): Cancer Research Program

ResearchPreceptor · Awarded by National Cancer Institute · 2023 - 2028

The Role of the DNA Sensor AIM2 in B Cell Fate and Function After HCT

ResearchPrincipal Investigator · Awarded by Leukemia & Lymphoma Society · 2024 - 2027

View All Grants

Education, Training & Certifications


Boston University · 1998 M.D.
Boston University, School of Medicine · 1998 Ph.D.